loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Open ICICI
3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

+91

BLOG

Sun Pharma has joined a White House agreement to expand access to affordable medicines

ICICIdirect Research 01 Sep 2026 DISCLAIMER

News: Sun Pharma has joined a White House agreement to expand access to affordable medicines in the U.S. The company will extend MFN pricing to state Medicaid programmes and commit to MFN pricing for future innovative launches. The pact also delays Section 232 tariffs on innovative drugs for over two years.

View: Under the Section 232 of the Trade Expansion Act of 1962 as imposed by the US government a 100% tariff will be imposed on imported patented pharmaceuticals and active pharmaceutical ingredients (APIs). Innovative Medicine portfolio currently account for 27% of the consolidated revenues and 75% of these Innovative medicine’s portfolio is from the US. This agreement will delay the section 232 tariffs for over two years. Sun Pharma also commits to MFN pricing for future innovative medicine launches which would be helpful for the post-merger product portfolio of Organon.

Impact: Positive

Download ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere

Download ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere